In focus · trending topic

Biotechnology

2092 stories · following the connections

AquaBounty Technologies, Inc. Results for the quarter ended March 31, 2018

By Nasdaq OMXMay 8, 2018, 8:45 PM UTC

Vital Therapies Announces First Quarter 2018 Financial Results

By Nasdaq OMXMay 8, 2018, 8:01 PM UTC

CrownBio Demonstrates Advantages of Innovative Translational Oncology Platform in Scientific Posters at AACR 2018 Meeting

By Nasdaq OMXMay 8, 2018, 12:02 PM UTC

Axsome Therapeutics Reports First Quarter 2018 Financial Results and Provides Business Update

By Nasdaq OMXMay 8, 2018, 11:01 AM UTC

Madrigal Pharmaceuticals Reports 2018 First Quarter Financial Results and Reviews Key Clinical Achievements

By Nasdaq OMXMay 8, 2018, 10:50 AM UTC

Exosome Diagnostics Expands National Sales Team after Blockbuster Quarter with its Flagship Diagnostic, ExoDx Prostate®(IntelliScore) (EPI) Test

By Nasdaq OMXMay 8, 2018, 10:30 AM UTC

BioCryst Reports First Quarter 2018 Financial Results

By Nasdaq OMXMay 8, 2018, 10:01 AM UTC

MacroGenics to Present at Deutsche Bank Health Care Conference

By Nasdaq OMXMay 7, 2018, 10:00 PM UTC